Daire A. Smith

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

Journal: ESMO open

Published: September 25, 2025

Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study.

Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 30, 2024

Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress.

Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 26, 2023

Neutron star mass estimates from gamma-ray eclipses in spider millisecond pulsar binaries.

Neutron star mass estimates from gamma-ray eclipses in spider millisecond pulsar binaries.

Journal: Nature astronomy

Published: January 21, 2022

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer.

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer.

Journal: PloS one

Published: July 21, 2020

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 14, 2019

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer.

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2017

How to manage a rectal cancer with synchronous liver metastases? A question of strategy

How to manage a rectal cancer with synchronous liver metastases? A question of strategy

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 25, 2017

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 23, 2017

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 12, 2016

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 11, 2015

Organ preserving strategies for rectal cancer treatment

Organ preserving strategies for rectal cancer treatment

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: May 10, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026